Squarepoint Ops »

4d Molecular Therapeutics In shares owned by Squarepoint Ops

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by Squarepoint Ops from 13F filings

Historical chart of Squarepoint Ops investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by Squarepoint Ops consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by Squarepoint Ops

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.3M 110k 20.99
2024-03-31 $466k 15k 31.86
2023-09-30 $608k 48k 12.73
2023-06-30 $266k 15k 18.07
2023-03-31 $1.1M 61k 17.19
2022-12-31 $1.4M 62k 22.21

More positions owned by Squarepoint Ops

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Msci Eafe Etf Put Option (EFA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple (AAPL)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Advanced Micro Devices Put Option (AMD)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Msci Brazil Etf Call Option (EWZ)
Tesla Motors Call Option (TSLA)
Pdd Holdings Sponsored Ads Call Option (PDD)

View all positions for Squarepoint Ops

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
BlackRock
VR Adviser
Goldman Sachs Group
Deep Track Capital
Henderson Group
Vanguard Group
State Street Corporation
Assenagon Asset Management
Novo A/S
Morgan Stanley
Redmile Group
Braidwell

View all funds holding 4d Molecular Therapeutics In